ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sluiter, H.
Right arrow Articles by Orie, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sluiter, H.
Right arrow Articles by Orie, N.
Eur Respir J 1991; 4: 479-489
Copyright © ERS Journals Ltd 1991


Original Articles

The Dutch hypothesis (chronic non-specific lung disease) revisited

HJ Sluiter, GH Koeter, JG de Monchy, DS Postma, K de Vries, and NG Orie

In 1961 the hypothesis (later referred to as the Dutch Hypothesis (DH)) was put forward that asthma, chronic bronchitis and emphysema should be considered as different expressions of one disease entity, in which both endogenous (host) and exogenous (environmental) factors play a role in the pathogenesis. A hereditary predisposition to develop allergy and bronchial hyperreactivity were considered to be important denominators of disease susceptibility. Complications and complicating diseases would also contribute to the ultimate phenotype of the patient. In the present paper we discuss the relevance of this hypothesis in 1990. Until now it has not been refuted; circumstantial evidence in its favour has accumulated, but formal proof is still lacking. Further research should pay more attention to the genetic aspects of the disease. Arguments are presented against the use of the terms asthma, chronic bronchitis, and emphysema as indicators of disease entities, and in favour of the use of an umbrella-term, e.g. chronic non-specific lung disease (CNSLD), provided that, in addition, every patient is characterized using so-called defining criteria.


This article has been cited by other articles:


Home page
Eur Respir JHome page
J-Q. He, K. Shumansky, J. E. Connett, N. R. Anthonisen, P. D. Pare, and A. J. Sandford
Association of genetic variations in the CSF2 and CSF3 genes with lung function in smoking-induced COPD
Eur. Respir. J., July 1, 2008; 32(1): 25 - 34.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
V. Bellia, C. Pedone, F. Catalano, A. Zito, E. Davi, S. Palange, F. Forastiere, and R. A. Incalzi
Asthma in the Elderly: Mortality Rate and Associated Risk Factors for Mortality
Chest, October 1, 2007; 132(4): 1175 - 1182.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
J. A. Elias, M. J. Kang, K. Crouthers, R. Homer, and C. G. Lee
State of the Art. Mechanistic Heterogeneity in Chronic Obstructive Pulmonary Disease: Insights from Transgenic Mice
Proceedings of the ATS, August 1, 2006; 3(6): 494 - 498.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. S. Postma, D. A. Meyers, H. Jongepier, T. D. Howard, G. H. Koppelman, and E. R. Bleecker
Genomewide Screen for Pulmonary Function in 200 Families Ascertained for Asthma
Am. J. Respir. Crit. Care Med., August 15, 2005; 172(4): 446 - 452.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. S. Postma and H. M. Boezen
Rationale for the Dutch Hypothesis: Allergy and Airway Hyperresponsiveness as Genetic Factors and Their Interaction With Environment in the Development of Asthma and COPD
Chest, August 1, 2004; 126(2_suppl_1): 96S - 104S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. Elias
The Relationship Between Asthma and COPD: Lessons From Transgenic Mice
Chest, August 1, 2004; 126(2_suppl_1): 111S - 116S.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
D. C. Grootendorst and K. F. Rabe
Mechanisms of Bronchial Hyperreactivity in Asthma and Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, April 1, 2004; 1(2): 77 - 87.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
The pharmacoepidemiology of COPD: Recent advances and methodological discussion
Eur. Respir. J., September 1, 2003; 22(43_suppl): 1s - 44s.
[Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J.-Q. He, J. E. Connett, N. R. Anthonisen, and A. J. Sandford
Polymorphisms in the IL13, IL13RA1, and IL4RA Genes and Rate of Decline in Lung Function in Smokers
Am. J. Respir. Cell Mol. Biol., March 1, 2003; 28(3): 379 - 385.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
F. Rasmussen, D. R. Taylor, E. M. Flannery, J. O. Cowan, J. M. Greene, G. P. Herbison, and M. R. Sears
Risk Factors for Airway Remodeling in Asthma Manifested by a Low Postbronchodilator FEV1/Vital Capacity Ratio: A Longitudinal Population Study from Childhood to Adulthood
Am. J. Respir. Crit. Care Med., June 1, 2002; 165(11): 1480 - 1488.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
S. Baldacci, E. Omenaas, and M.P. Oryszczyn
Allergy markers in respiratory epidemiology
Eur. Respir. J., April 1, 2001; 17(4): 773 - 790.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
F. Rasmussen, H. C. Siersted, J. Lambrechtsen, H. S. Hansen, and N.-C. G. Hansen
Impact of Airway Lability, Atopy, and Tobacco Smoking on the Development of Asthma-Like Symptoms in Asymptomatic Teenagers
Chest, May 1, 2000; 117(5): 1330 - 1335.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
M. R Becklake and F. Kauffmann
Gender differences in airway behaviour over the human life span
Thorax, December 1, 1999; 54(12): 1119 - 1138.
[Full Text]


Home page
NEJMHome page
H. A. Boushey
Glucocorticoid Therapy for Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., June 24, 1999; 340(25): 1990 - 1991.
[Full Text]


Home page
NEJMHome page
P. Lange, J. Parner, J. Vestbo, P. Schnohr, and G. Jensen
A 15-Year Follow-Up Study of Ventilatory Function in Adults with Asthma
N. Engl. J. Med., October 22, 1998; 339(17): 1194 - 1200.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. I. M. PANHUYSEN, E. R. BLEECKER, G. H. KOETER, D. A. MEYERS, and D. S. POSTMA
Characterization of Obstructive Airway Disease in Family Members of Probands with Asthma . An Algorithm for the Diagnosis of Asthma
Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1734 - 1742.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. M. SENIOR and N. R. ANTHONISEN
Chronic Obstructive Pulmonary Disease (COPD)
Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): S139 - S147.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
N. M. CLARK, W. C. BAILEY, and C. RAND
Advances in Prevention and Education in Lung Disease
Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): S155 - S167.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. H. BODNER, S. ROSS, J. LITTLE, J. GRAHAM DOUGLAS, J. S. LEGGE, J. A. R. FRIEND, and D. J. GODDEN
Risk Factors for Adult Onset Wheeze . A Case Control Study
Am. J. Respir. Crit. Care Med., January 1, 1997; 157(1): 35 - 42.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the European Respiratory Society.